Pfizer Awaits Fablyn Probe
On Monday, the FDA will say if the pharma's osteoporosis drug has more pros than cons. 2 months ago
Forbes Click here to Read the Full StoryOn Monday, the FDA will say if the pharma's osteoporosis drug has more pros than cons. 2 months ago
Forbes Click here to Read the Full Story
Digg
del.icio.us
Reddit
Stumble
Newsvine
Facebook